Increasingly, large-scale analyses of biobank samples are undertaken at levels of DNA and RNA, but opportunities for extensive protein analyses have lagged behind. The proximity ligation technology allows high-performance analyses of plasma samples from patients and controls with readout via next generation sequencing.